SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-258852
Filing Date
2022-10-06
Accepted
2022-10-06 16:08:36
Documents
13
Period of Report
2022-10-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d380272d8k.htm   iXBRL 8-K 34604
  Complete submission text file 0001193125-22-258852.txt   198572

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA celu-20221004.xsd EX-101.SCH 4498
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE celu-20221004_def.xml EX-101.DEF 13889
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE celu-20221004_lab.xml EX-101.LAB 23346
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE celu-20221004_pre.xml EX-101.PRE 14851
7 EXTRACTED XBRL INSTANCE DOCUMENT d380272d8k_htm.xml XML 5876
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

IRS No.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38914 | Film No.: 221298271
SIC: 2834 Pharmaceutical Preparations